Progressive Care Expands COVID-19 Testing With 15 Minute Antigen Rapid Tests
Miami, FL -- October 8, 2020 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD) ("Progressive Care" or the "Company"), a personalized
healthcare services and technology company, is excited to announce
that the Company has launched an aggressive expansion of its
COVID-19 testing service registered through the FDA under its
Emergency Use Authorization ("EUA") guidelines, featuring an
Antigen testing system that produces rapid detection of the
SARS-CoV-2 virus with market-leading accuracy in 15 minutes.
Cannot view this video? Visit:
"We are seeing very strong demand for our rapid results antigen
tests, both at our PharmCo locations and where we are called to
administer and analyze on-site for customers," commented Alan Jay
Weisberg, interim CEO and Chairman of the Board at Progressive
Care. "We have received our first order of more than 700 tests and
have access to large supplies to meet the needs for future
The BD Veritor System for Rapid Detection of the SARS-CoV-2
virus is an antigen-based testing system designed to detect
proteins from the virus that causes COVID-19 when applied to
respiratory specimens such as those produced through nasal
swabbing. Data shows exceptional accuracy of results, with fewer
than 2% of every 1,000 tests producing a false negative result and
fewer than 1% of every 1,000 tests producing a false positive
The Company has already rolled out these expanded rapid results
testing services in the Miami metropolitan area, and it intends to
expand this service to all PharmCo locations over coming weeks.
Management notes that the Company's testing service already shows
signs of regional market leadership, as indicated by its related
website now trending at or near the top in internet search results
for COVID-19 testing in Miami.
Weisberg added, "As our economy reopens and with the looming
return of cold and flu season, and early signs of a likely
resurgence in Covid-19 cases as a seasonal risk in the northern
hemisphere, testing will be our most important frontline defense
ahead of vaccine, which experts believe may still be many months
away in terms of access for most people. Progressive Care is
grateful for the opportunity to provide an effective resource for
our surrounding communities."
For more information about Progressive Care, please visit the
Connect and stay in touch with us on social media:
Progressive Care Inc.
About Progressive Care Inc.
Progressive Care Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company's
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding our planned expansion of the testing services to all
PharmCo locations in the coming weeks, access to supplies, our
placement in the market and future demand for our services. When
used herein, the words "anticipate," "believe," "estimate,"
"upcoming," "plan," "target," "intend" and "expect" and similar
expressions, as they relate to Progressive Care Inc., its
subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number of risks, uncertainties, and other factors that
could cause the Company's actual results, performance, prospects,
and opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Public Relations Contact: